Veracyte's Shares Rise Sharply in December, but MDx/Omics Tools Stocks Decline Slightly | GenomeWeb

NEW YORK (GenomeWeb) – Shares of Veracyte were up 48 percent month over month in December pacing the gainers in the GenomeWeb Daily News Index, which overall was essentially flat during the month. 

The GWDN Index was down a fraction of 1 percent from November despite the large gain by Veracyte, as well as significant jumps in the shares of Vermillion (+26 percent), Sequenom (+23 percent), and GenMark Diagnostics (+20 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.